BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 25335165)

  • 1. Menopausal hormone therapy and central nervous system tumor risk: large UK prospective study and meta-analysis.
    Benson VS; Kirichek O; Beral V; Green J
    Int J Cancer; 2015 May; 136(10):2369-77. PubMed ID: 25335165
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Menopausal hormone therapy and central nervous system tumors: Danish nested case-control study.
    Pourhadi N; Meaidi A; Friis S; Torp-Pedersen C; Mørch LS
    PLoS Med; 2023 Dec; 20(12):e1004321. PubMed ID: 38113227
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mobile phone use and risk of brain neoplasms and other cancers: prospective study.
    Benson VS; Pirie K; Schüz J; Reeves GK; Beral V; Green J;
    Int J Epidemiol; 2013 Jun; 42(3):792-802. PubMed ID: 23657200
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reproductive factors and exogenous hormone use in relation to risk of glioma and meningioma in a large European cohort study.
    Michaud DS; Gallo V; Schlehofer B; Tjønneland A; Olsen A; Overvad K; Dahm CC; Kaaks R; Lukanova A; Boeing H; Schütze M; Trichopoulou A; Bamia C; Kyrozis A; Sacerdote C; Agnoli C; Palli D; Tumino R; Mattiello A; Bueno-de-Mesquita HB; Ros MM; Peeters PH; van Gils CH; Lund E; Bakken K; Gram IT; Barricarte A; Navarro C; Dorronsoro M; Sánchez MJ; Rodríguez L; Duell EJ; Hallmans G; Melin BS; Manjer J; Borgquist S; Khaw KT; Wareham N; Allen NE; Tsilidis KK; Romieu I; Rinaldi S; Vineis P; Riboli E
    Cancer Epidemiol Biomarkers Prev; 2010 Oct; 19(10):2562-9. PubMed ID: 20802020
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hormone replacement therapy and incidence of central nervous system tumours in the Million Women Study.
    Benson VS; Pirie K; Green J; Bull D; Casabonne D; Reeves GK; Beral V;
    Int J Cancer; 2010 Oct; 127(7):1692-8. PubMed ID: 20091865
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Menopausal hormone therapy and risk of melanoma: Do estrogens and progestins have a different role?
    Botteri E; Støer NC; Sakshaug S; Graff-Iversen S; Vangen S; Hofvind S; Ursin G; Weiderpass E
    Int J Cancer; 2017 Nov; 141(9):1763-1770. PubMed ID: 28685818
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Personal hair dye use and risks of glioma, meningioma, and acoustic neuroma among adults.
    Bluhm EC; Zahm SH; Fine HA; Black PM; Loeffler JS; Shapiro WR; Selker RG; Inskip PD
    Am J Epidemiol; 2007 Jan; 165(1):63-71. PubMed ID: 17079691
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Breast cancer risk in relation to the interval between menopause and starting hormone therapy.
    Beral V; Reeves G; Bull D; Green J;
    J Natl Cancer Inst; 2011 Feb; 103(4):296-305. PubMed ID: 21278356
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Venous thromboembolism risk in relation to use of different types of postmenopausal hormone therapy in a large prospective study.
    Sweetland S; Beral V; Balkwill A; Liu B; Benson VS; Canonico M; Green J; Reeves GK;
    J Thromb Haemost; 2012 Nov; 10(11):2277-86. PubMed ID: 22963114
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Menopausal hormone therapy and risk of gastrointestinal cancer: nested case-control study within a prospective cohort, and meta-analysis.
    Green J; Czanner G; Reeves G; Watson J; Wise L; Roddam A; Beral V
    Int J Cancer; 2012 May; 130(10):2387-96. PubMed ID: 21671473
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radiation risk of central nervous system tumors in the Life Span Study of atomic bomb survivors, 1958-2009.
    Brenner AV; Sugiyama H; Preston DL; Sakata R; French B; Sadakane A; Cahoon EK; Utada M; Mabuchi K; Ozasa K
    Eur J Epidemiol; 2020 Jun; 35(6):591-600. PubMed ID: 31982981
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reproductive factors, menopausal hormone therapies and primary liver cancer risk: a systematic review and dose-response meta-analysis of observational studies.
    Zhong GC; Liu Y; Chen N; Hao FB; Wang K; Cheng JH; Gong JP; Ding X
    Hum Reprod Update; 2016 Dec; 23(1):126-138. PubMed ID: 27655589
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Cell Phones and Risk of brain and acoustic nerve tumours: the French INTERPHONE case-control study].
    Hours M; Bernard M; Montestrucq L; Arslan M; Bergeret A; Deltour I; Cardis E
    Rev Epidemiol Sante Publique; 2007 Oct; 55(5):321-32. PubMed ID: 17851009
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Growth hormone exposure as a risk factor for the development of subsequent neoplasms of the central nervous system: a report from the childhood cancer survivor study.
    Patterson BC; Chen Y; Sklar CA; Neglia J; Yasui Y; Mertens A; Armstrong GT; Meadows A; Stovall M; Robison LL; Meacham LR
    J Clin Endocrinol Metab; 2014 Jun; 99(6):2030-7. PubMed ID: 24606096
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lessons learned from the Women's Health Initiative trials of menopausal hormone therapy.
    Rossouw JE; Manson JE; Kaunitz AM; Anderson GL
    Obstet Gynecol; 2013 Jan; 121(1):172-6. PubMed ID: 23262943
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is estrogen plus progestin menopausal hormone therapy safe with respect to endometrial cancer risk?
    Trabert B; Wentzensen N; Yang HP; Sherman ME; Hollenbeck AR; Park Y; Brinton LA
    Int J Cancer; 2013 Jan; 132(2):417-26. PubMed ID: 22553145
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Menopausal hormone therapy and risk of epithelial ovarian cancer.
    Rossing MA; Cushing-Haugen KL; Wicklund KG; Doherty JA; Weiss NS
    Cancer Epidemiol Biomarkers Prev; 2007 Dec; 16(12):2548-56. PubMed ID: 18086757
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mobile phone use and brain tumour risk - COSMOS, a prospective cohort study.
    Feychting M; Schüz J; Toledano MB; Vermeulen R; Auvinen A; Harbo Poulsen A; Deltour I; Smith RB; Heller J; Kromhout H; Huss A; Johansen C; Tettamanti G; Elliott P
    Environ Int; 2024 Mar; 185():108552. PubMed ID: 38458118
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Obesity and Risk for Brain/CNS Tumors, Gliomas and Meningiomas: A Meta-Analysis.
    Sergentanis TN; Tsivgoulis G; Perlepe C; Ntanasis-Stathopoulos I; Tzanninis IG; Sergentanis IN; Psaltopoulou T
    PLoS One; 2015; 10(9):e0136974. PubMed ID: 26332834
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association between brain tumors and menopausal status.
    Schlehofer B; Blettner M; Wahrendorf J
    J Natl Cancer Inst; 1992 Sep; 84(17):1346-9. PubMed ID: 1495104
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.